{"id": "article-18745_0", "title": "C1 Esterase Inhibitor Deficiency -- Continuing Education Activity", "content": "C1 esterase inhibitor deficiency, also known as hereditary angioedema, results in the unchecked production of the vasodilator bradykinin. This increase in bradykinin leads to an increase in smooth muscle relaxation in the walls of blood vessels and resultant edema in the hands, feet, gastrointestinal tract, and in severe cases, the larynx. In severe cases, the airway can be compromised and effectively swollen closed, preventing air movement into and out of the lungs. This activity reviews the presentation, evaluation, and management of C1 esterase inhibitor deficiency, and highlights the role of the interprofessional team in caring for patients with this condition.", "contents": "C1 Esterase Inhibitor Deficiency -- Continuing Education Activity. C1 esterase inhibitor deficiency, also known as hereditary angioedema, results in the unchecked production of the vasodilator bradykinin. This increase in bradykinin leads to an increase in smooth muscle relaxation in the walls of blood vessels and resultant edema in the hands, feet, gastrointestinal tract, and in severe cases, the larynx. In severe cases, the airway can be compromised and effectively swollen closed, preventing air movement into and out of the lungs. This activity reviews the presentation, evaluation, and management of C1 esterase inhibitor deficiency, and highlights the role of the interprofessional team in caring for patients with this condition."}
{"id": "article-18745_1", "title": "C1 Esterase Inhibitor Deficiency -- Continuing Education Activity", "content": "Objectives: Describe the pertinent history and physical exam findings in a patient with C1 esterase inhibitor deficiency. Review the presumptive versus the definitive diagnosis of C1 esterase inhibitor deficiency. Summarize the management options available for C1 esterase inhibitor deficiency. Explain how interprofessional teams can improve care coordination and communication to advance treatment for patients with C1 esterase inhibitor deficiency. Access free multiple choice questions on this topic.", "contents": "C1 Esterase Inhibitor Deficiency -- Continuing Education Activity. Objectives: Describe the pertinent history and physical exam findings in a patient with C1 esterase inhibitor deficiency. Review the presumptive versus the definitive diagnosis of C1 esterase inhibitor deficiency. Summarize the management options available for C1 esterase inhibitor deficiency. Explain how interprofessional teams can improve care coordination and communication to advance treatment for patients with C1 esterase inhibitor deficiency. Access free multiple choice questions on this topic."}
{"id": "article-18745_2", "title": "C1 Esterase Inhibitor Deficiency -- Introduction", "content": "Hereditary angioedema,\u00a0otherwise known as\u00a0C1 esterase deficiency, is defined by recurrent episodes of angioedema without urticaria or pruritus. These skin conditions typically involve the legs,\u00a0hands, face,\u00a0upper respiratory tract, as well as gastrointestinal tract. This disorder can lead to airway edema and potentially asphyxiation due to laryngeal swelling. Associated symptoms typically include abdominal pain and vomiting\u00a0secondary to gastrointestinal involvement. [1]", "contents": "C1 Esterase Inhibitor Deficiency -- Introduction. Hereditary angioedema,\u00a0otherwise known as\u00a0C1 esterase deficiency, is defined by recurrent episodes of angioedema without urticaria or pruritus. These skin conditions typically involve the legs,\u00a0hands, face,\u00a0upper respiratory tract, as well as gastrointestinal tract. This disorder can lead to airway edema and potentially asphyxiation due to laryngeal swelling. Associated symptoms typically include abdominal pain and vomiting\u00a0secondary to gastrointestinal involvement. [1]"}
{"id": "article-18745_3", "title": "C1 Esterase Inhibitor Deficiency -- Etiology", "content": "Hereditary angioedema results from excessive production of bradykinin. Bradykinin is a vasodilator that causes the larynx to become engorged and swollen, threatening the airway. Due to this pathway, the swelling is not amenable to antihistamines as it is not a histamine-mediated process. While there are other forms of hereditary angioedema, deficiency or dysfunction in C1 inhibitor is the most common form. C1 inhibitor is an acute phase reactant and a serine protease inhibitor (serpin). Serpins inhibit the steps in the lectin complement pathway as well as kinin-producing pathways. While C1 inhibitor has many functions, its function in the kinin pathway leads to angioedema. [2]", "contents": "C1 Esterase Inhibitor Deficiency -- Etiology. Hereditary angioedema results from excessive production of bradykinin. Bradykinin is a vasodilator that causes the larynx to become engorged and swollen, threatening the airway. Due to this pathway, the swelling is not amenable to antihistamines as it is not a histamine-mediated process. While there are other forms of hereditary angioedema, deficiency or dysfunction in C1 inhibitor is the most common form. C1 inhibitor is an acute phase reactant and a serine protease inhibitor (serpin). Serpins inhibit the steps in the lectin complement pathway as well as kinin-producing pathways. While C1 inhibitor has many functions, its function in the kinin pathway leads to angioedema. [2]"}
{"id": "article-18745_4", "title": "C1 Esterase Inhibitor Deficiency -- Etiology", "content": "While it is uncertain what causes the initial molecular events leading to this angioedema, it is believed activated factor XII of the coagulation cascade and kallikrein catalyze the cleavage of kininogen, which produces bradykinin. C1 inhibitor usually limits this bradykinin production by inhibiting kallikrein and factor XIIa. Bradykinin\u00a0is a potent vasodilator\u00a0due\u00a0to multifactorial downstream effects on the smooth muscle in blood vessels. This activity, in turn, leads to edema of surrounding tissues and, most importantly,\u00a0the airway.\u00a0In individuals with a deficiency of C1 inhibitor, this process proceeds unchecked and leads to gross vasodilation and angioedema. [1]", "contents": "C1 Esterase Inhibitor Deficiency -- Etiology. While it is uncertain what causes the initial molecular events leading to this angioedema, it is believed activated factor XII of the coagulation cascade and kallikrein catalyze the cleavage of kininogen, which produces bradykinin. C1 inhibitor usually limits this bradykinin production by inhibiting kallikrein and factor XIIa. Bradykinin\u00a0is a potent vasodilator\u00a0due\u00a0to multifactorial downstream effects on the smooth muscle in blood vessels. This activity, in turn, leads to edema of surrounding tissues and, most importantly,\u00a0the airway.\u00a0In individuals with a deficiency of C1 inhibitor, this process proceeds unchecked and leads to gross vasodilation and angioedema. [1]"}
{"id": "article-18745_5", "title": "C1 Esterase Inhibitor Deficiency -- Epidemiology", "content": "Hereditary angioedema has an incidence of approximately 1 in 50000 individuals. While there are nearly 300 pathogenic variants, most are inherited in an autosomal dominant fashion, with approximately 25% of cases arising from de novo mutations. This condition leads to about 15000 to 30000 emergency department visits per year. [1]", "contents": "C1 Esterase Inhibitor Deficiency -- Epidemiology. Hereditary angioedema has an incidence of approximately 1 in 50000 individuals. While there are nearly 300 pathogenic variants, most are inherited in an autosomal dominant fashion, with approximately 25% of cases arising from de novo mutations. This condition leads to about 15000 to 30000 emergency department visits per year. [1]"}
{"id": "article-18745_6", "title": "C1 Esterase Inhibitor Deficiency -- Pathophysiology", "content": "The most clinically significant sequelae of C1 inhibitor deficiency is the potential for laryngeal edema and subsequent asphyxiation due to angioedema from unchecked bradykinin effects. The pathophysiology of C1 esterase inhibitor deficiency largely stems from the increased bradykinin production. Increased levels of bradykinin then lead to smooth muscle relaxation in the walls of blood vessels which causes edema. If severe enough, the airway can be compromised and effectively\u00a0swollen closed, preventing air movement into and\u00a0out of the lungs. [3]", "contents": "C1 Esterase Inhibitor Deficiency -- Pathophysiology. The most clinically significant sequelae of C1 inhibitor deficiency is the potential for laryngeal edema and subsequent asphyxiation due to angioedema from unchecked bradykinin effects. The pathophysiology of C1 esterase inhibitor deficiency largely stems from the increased bradykinin production. Increased levels of bradykinin then lead to smooth muscle relaxation in the walls of blood vessels which causes edema. If severe enough, the airway can be compromised and effectively\u00a0swollen closed, preventing air movement into and\u00a0out of the lungs. [3]"}
{"id": "article-18745_7", "title": "C1 Esterase Inhibitor Deficiency -- History and Physical", "content": "When suspecting C1 esterase deficiency, key historical findings such as a family history for the disease or upper airway swelling may be noted. Additionally, a history of unexplained recurrent episodes of self-limited colicky abdominal pain may be present. History of angioedema without urticaria, pruritus, ACE inhibitor, NSAID, or allergic exposure is highly suggestive\u00a0as well. Common sites that are affected include the hands and feet\u00a0as well. [1]", "contents": "C1 Esterase Inhibitor Deficiency -- History and Physical. When suspecting C1 esterase deficiency, key historical findings such as a family history for the disease or upper airway swelling may be noted. Additionally, a history of unexplained recurrent episodes of self-limited colicky abdominal pain may be present. History of angioedema without urticaria, pruritus, ACE inhibitor, NSAID, or allergic exposure is highly suggestive\u00a0as well. Common sites that are affected include the hands and feet\u00a0as well. [1]"}
{"id": "article-18745_8", "title": "C1 Esterase Inhibitor Deficiency -- Evaluation", "content": "When\u00a0suspecting C1 esterase inhibitor deficiency, it may present with airway compromise from laryngeal edema or a more benign presentation of unexplained\u00a0hands and foot swelling. First, care should be taken to ensure the airway is secured; this can be via traditional airway methods but will be made difficult due to airway swelling. Further evaluation should take place on a trial basis of classic allergic airway swelling management (epinephrine, steroids, antihistamines). In the case of C1 inhibitor deficiency, these methods will not work. At this point, a presumptive diagnosis can be made,\u00a0but for a definitive diagnosis, clinicians can obtain C4 levels. In the case of C1 inhibitor deficiency, C4 levels will be low. Further testing can include C1NH protein levels and function studies for definitive diagnosis. [4]", "contents": "C1 Esterase Inhibitor Deficiency -- Evaluation. When\u00a0suspecting C1 esterase inhibitor deficiency, it may present with airway compromise from laryngeal edema or a more benign presentation of unexplained\u00a0hands and foot swelling. First, care should be taken to ensure the airway is secured; this can be via traditional airway methods but will be made difficult due to airway swelling. Further evaluation should take place on a trial basis of classic allergic airway swelling management (epinephrine, steroids, antihistamines). In the case of C1 inhibitor deficiency, these methods will not work. At this point, a presumptive diagnosis can be made,\u00a0but for a definitive diagnosis, clinicians can obtain C4 levels. In the case of C1 inhibitor deficiency, C4 levels will be low. Further testing can include C1NH protein levels and function studies for definitive diagnosis. [4]"}
{"id": "article-18745_9", "title": "C1 Esterase Inhibitor Deficiency -- Treatment / Management", "content": "Management of C1 esterase inhibitor deficiency is mostly in response to airway compromise. If only mild symptoms present and the patient has a known diagnosis, it is reasonable to manage conservatively with observation. If more severe symptoms and impending airway compromise are present, a definitive airway is necessary. Presumptive treatment with epinephrine, steroids, and antihistamines is recommended\u00a0of the undifferentiated patient with airway compromise secondary to laryngeal edema. However, in the setting of C1 esterase inhibitor deficiency, this is ineffective but should be attempted as allergic airway compromise is more common, and these methods have a high reward with relatively little downside. [5]", "contents": "C1 Esterase Inhibitor Deficiency -- Treatment / Management. Management of C1 esterase inhibitor deficiency is mostly in response to airway compromise. If only mild symptoms present and the patient has a known diagnosis, it is reasonable to manage conservatively with observation. If more severe symptoms and impending airway compromise are present, a definitive airway is necessary. Presumptive treatment with epinephrine, steroids, and antihistamines is recommended\u00a0of the undifferentiated patient with airway compromise secondary to laryngeal edema. However, in the setting of C1 esterase inhibitor deficiency, this is ineffective but should be attempted as allergic airway compromise is more common, and these methods have a high reward with relatively little downside. [5]"}
{"id": "article-18745_10", "title": "C1 Esterase Inhibitor Deficiency -- Treatment / Management", "content": "Specific therapy for C1 esterase inhibitor deficiency with laryngeal edema involves replacing the deficient enzyme. The easiest way is to give human plasma, which contains C1 esterase inhibitor. An initial dose of human plasma is 2 units.\u00a0C1INH concentrate derived\u00a0from human plasma may be a therapeutic option.\u00a0The initial dose is 1500 units. [6]", "contents": "C1 Esterase Inhibitor Deficiency -- Treatment / Management. Specific therapy for C1 esterase inhibitor deficiency with laryngeal edema involves replacing the deficient enzyme. The easiest way is to give human plasma, which contains C1 esterase inhibitor. An initial dose of human plasma is 2 units.\u00a0C1INH concentrate derived\u00a0from human plasma may be a therapeutic option.\u00a0The initial dose is 1500 units. [6]"}
{"id": "article-18745_11", "title": "C1 Esterase Inhibitor Deficiency -- Treatment / Management", "content": "More specific, less widely used medications include Icatibant and ecallantide. Icatibant\u00a0is a synthetic bradykinin B2-receptor antagonist, while ecallantide is a recombinant plasma kallikrein inhibitor. [5] [6]", "contents": "C1 Esterase Inhibitor Deficiency -- Treatment / Management. More specific, less widely used medications include Icatibant and ecallantide. Icatibant\u00a0is a synthetic bradykinin B2-receptor antagonist, while ecallantide is a recombinant plasma kallikrein inhibitor. [5] [6]"}
{"id": "article-18745_12", "title": "C1 Esterase Inhibitor Deficiency -- Differential Diagnosis", "content": "Differential diagnosis in the setting of airway edema includes: Anaphylaxis/allergic ACE inhibitor-induced edema Idiopathic Autoimmune disorders Superior vena cava syndrome Thyroid disorders Cheilitis granulomatosa Trichinosis The possible differentials can broaden when symptoms relate solely to extremity swelling: Lymphedema Deep vein thrombosis Cellulitis", "contents": "C1 Esterase Inhibitor Deficiency -- Differential Diagnosis. Differential diagnosis in the setting of airway edema includes: Anaphylaxis/allergic ACE inhibitor-induced edema Idiopathic Autoimmune disorders Superior vena cava syndrome Thyroid disorders Cheilitis granulomatosa Trichinosis The possible differentials can broaden when symptoms relate solely to extremity swelling: Lymphedema Deep vein thrombosis Cellulitis"}
{"id": "article-18745_13", "title": "C1 Esterase Inhibitor Deficiency -- Prognosis", "content": "Depending on the response to therapy, the patient should return to normal health. Occasionally patients are very\u00a0resistant to therapy and will require intubation. After the acute event and extubation, the patient should have a full recovery.\u00a0The chance of recurrence, however, is always present. [7]", "contents": "C1 Esterase Inhibitor Deficiency -- Prognosis. Depending on the response to therapy, the patient should return to normal health. Occasionally patients are very\u00a0resistant to therapy and will require intubation. After the acute event and extubation, the patient should have a full recovery.\u00a0The chance of recurrence, however, is always present. [7]"}
{"id": "article-18745_14", "title": "C1 Esterase Inhibitor Deficiency -- Complications", "content": "The most severe complication is airway compromise requiring intubation or surgical airway; standard airway procedures and protocols should manage this situation. [6]", "contents": "C1 Esterase Inhibitor Deficiency -- Complications. The most severe complication is airway compromise requiring intubation or surgical airway; standard airway procedures and protocols should manage this situation. [6]"}
{"id": "article-18745_15", "title": "C1 Esterase Inhibitor Deficiency -- Consultations", "content": "If attempts at the airway are unsuccessful, a surgical airway may be necessary. Consultation with the anesthesia team may be of some benefit if there is a possibility of a difficult airway.", "contents": "C1 Esterase Inhibitor Deficiency -- Consultations. If attempts at the airway are unsuccessful, a surgical airway may be necessary. Consultation with the anesthesia team may be of some benefit if there is a possibility of a difficult airway."}
{"id": "article-18745_16", "title": "C1 Esterase Inhibitor Deficiency -- Deterrence and Patient Education", "content": "Avoid physical and psychological stressors. Medications to avoid include: estrogen, tamoxifen, and ACE inhibitors Patients who\u00a0are to undergo oral surgery should receive prophylaxis which includes attenuated androgens, regular C1INH infusions, and\u00a0tranexamic\u00a0acid infusion", "contents": "C1 Esterase Inhibitor Deficiency -- Deterrence and Patient Education. Avoid physical and psychological stressors. Medications to avoid include: estrogen, tamoxifen, and ACE inhibitors Patients who\u00a0are to undergo oral surgery should receive prophylaxis which includes attenuated androgens, regular C1INH infusions, and\u00a0tranexamic\u00a0acid infusion"}
{"id": "article-18745_17", "title": "C1 Esterase Inhibitor Deficiency -- Enhancing Healthcare Team Outcomes", "content": "When caring for a patient with hereditary angioedema, the ABCs of resuscitation should\u00a0be first and\u00a0foremost. Assigning team roles and frequently assessing the patient for airway compromise is paramount. Having the appropriate\u00a0tools for intubation, such as visual\u00a0laryngoscopes and backup airway devices, is part of the\u00a0key to success. Patients with even concern for airway compromise should be monitored closely in the intensive care setting. [6]", "contents": "C1 Esterase Inhibitor Deficiency -- Enhancing Healthcare Team Outcomes. When caring for a patient with hereditary angioedema, the ABCs of resuscitation should\u00a0be first and\u00a0foremost. Assigning team roles and frequently assessing the patient for airway compromise is paramount. Having the appropriate\u00a0tools for intubation, such as visual\u00a0laryngoscopes and backup airway devices, is part of the\u00a0key to success. Patients with even concern for airway compromise should be monitored closely in the intensive care setting. [6]"}
{"id": "article-18745_18", "title": "C1 Esterase Inhibitor Deficiency -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "C1 Esterase Inhibitor Deficiency -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}